INFORMAZIONI SU QUESTO EPISODIO
The CDER NextGen Portal (or the “Portal” for short) has made it easier than ever for regulated industry to communicate with the FDA.
Inglese
Stati Uniti
TRASCRIZIONE 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
CERCA TRA GLI EPISODI PASSATI
Cerca gli episodi passati di FDA CDER Small Business and Industry Assistance (SBIA) Chronicles.
ALTRI EPISODI IN QUESTO PODCAST
The Role of Pharmacodynamic Biomarkers in Biosimilar Drug Development
Continuous manufacturing (CM) technology has the potential to improve product quality and reliability, lower manufacturing costs, reduce waste, decrease inventory, and increase manufacturing flexibility and agility in response to product demand.
FDA Regulation and Quality Considerations for Cannabis and Cannabis-Derived Compounds
The FDA Compounding Incidents Program: Adverse Events Associated with Compounded Drugs from Outsourcing Facilities
Dichiarazione di non responsabilità: Il podcast e la grafica incorporati in questa pagina provengono da U.S. Food and Drug Administration, Center for Drug Evaluation and Research, che è di proprietà del suo proprietario e non è affiliato o approvato da Listen Notes, Inc.
MODIFICA
Grazie, ci hai aiutato a mantenere aggiornato il database dei podcast.
